Xeris Pharmaceuticals

Xeris is a specialty biopharmaceutical company providing innovative solutions to simplify the experience of essential treatments that people around the world rely on every day. Through a novel technology platform enabling the immediate use and room-temperature stability of injectable and insoluble therapies, the company is advancing a portfolio of solutions across various therapeutic categories, including its first commercial product, Gvoke®. The proprietary XeriSol™ and XeriJect™ formulation technologies in the U.S. have the potential to offer unique advantages over traditional product formulations, including eliminating the need for reconstitution, enabling long-term room-temperature stability, significantly reducing injection volumes, and removing the need for intravenous infusion. Leveraging Xeris’ technology, new product formulations are designed to be more user-friendly for patients, caregivers, and healthcare providers while helping to reduce costs for payers and healthcare systems.